Update to “Homologous Recombination Repair Defect May Predict Treatment Response to Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors”

Mojun Zhu; Tanios Bekaii-Saab

doi:10.1093/oncolo/oyac068

Update to “Homologous Recombination Repair Defect May Predict Treatment Response to Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors”

Hematology/Oncology

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	E534-E535
Journal	Oncologist
Volume	27
Issue number	6
DOIs	https://doi.org/10.1093/oncolo/oyac068
State	Published - Jun 2022

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1093/oncolo/oyac068

Cite this

@article{1e75d900704249f19ea053b09d1788aa,

title = "Update to “Homologous Recombination Repair Defect May Predict Treatment Response to Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors”",

author = "Mojun Zhu and Tanios Bekaii-Saab",

year = "2022",

month = jun,

doi = "10.1093/oncolo/oyac068",

language = "English (US)",

volume = "27",

pages = "E534--E535",

journal = "Oncologist",

issn = "1083-7159",

publisher = "AlphaMed Press",

number = "6",

}

TY - JOUR

T1 - Update to “Homologous Recombination Repair Defect May Predict Treatment Response to Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors”

AU - Zhu, Mojun

AU - Bekaii-Saab, Tanios

PY - 2022/6

Y1 - 2022/6

UR - http://www.scopus.com/inward/record.url?scp=85131770621&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85131770621&partnerID=8YFLogxK

U2 - 10.1093/oncolo/oyac068

DO - 10.1093/oncolo/oyac068

M3 - Letter

C2 - 35403684

AN - SCOPUS:85131770621

SN - 1083-7159

VL - 27

SP - E534-E535

JO - Oncologist

JF - Oncologist

IS - 6

ER -

Update to “Homologous Recombination Repair Defect May Predict Treatment Response to Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors”

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this